Cross Country Healthcare (NASDAQ:CCRN) Price Target Lowered to $26.00 at Barrington Research
Cross Country Healthcare (NASDAQ:CCRN – Free Report) had its price target trimmed by Barrington Research from $29.00 to $26.00 in a research note published on...
Incyte (NASDAQ:INCY) Given Buy Rating at Truist Financial
Truist Financial reaffirmed their buy rating on shares of Incyte (NASDAQ:INCY – Free Report) in a research note released on Wednesday, Benzinga reports. They currently...
CrowdStrike (NASDAQ:CRWD) Price Target Raised to $240.00
CrowdStrike (NASDAQ:CRWD – Free Report) had its target price boosted by Canaccord Genuity Group from $221.00 to $240.00 in a research note issued to investors...
Morgan Stanley Increases CrowdStrike (NASDAQ:CRWD) Price Target to $203.00
CrowdStrike (NASDAQ:CRWD – Free Report) had its target price hoisted by Morgan Stanley from $187.00 to $203.00 in a report published on Wednesday, Benzinga reports....
For Chris Davis, retirement from Orioles has meant more time to give back
Before his first public appearance at Camden Yards since he retired, Chris Davis wasn’t nervous, but the longtime Orioles first baseman recognized he could have...
For Chris Davis, retirement from Orioles has meant more time to give back
Before his first public appearance at Camden Yards since he retired, Chris Davis wasn’t nervous, but the longtime Orioles first baseman recognized he could have...